[Bacterial meningitis from a gastrointestinal source].
Denève
E
E
Sebbane
M
M
Chanque
G
G
Bapin
C
C
Jaber
S
S
Fabre
J M
JM
Nocca
D
D
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003113:Colonoscopy; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use; D005673:Fusobacterium / Q000302:isolation & purification; D005674:Fusobacterium Infections / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016920:Meningitis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008875:Middle Aged; D011126:Polypropylenes; D011183:Postoperative Complications; D012003:Rectal Fistula / Q000150:complications* / Q000000981:diagnostic imaging / Q000209:etiology / Q000382:microbiology / Q000601:surgery; D012005:Rectal Prolapse / Q000601:surgery*; D013290:Streptococcal Infections / Q000188:drug therapy / Q000209:etiology*; D013291:Streptococcus / Q000302:isolation & purification; D013526:Surgical Mesh / Q000009:adverse effects*; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011126:Polypropylenes; D005578:Fosfomycin; D014640:Vancomycin; D002439:Cefotaxime